wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37119868-F32CC0EE-1CD7-41F4-BDC3-63C08265523E
Q37119868-F32CC0EE-1CD7-41F4-BDC3-63C08265523E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37119868-F32CC0EE-1CD7-41F4-BDC3-63C08265523E
Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies.
P2860
Q37119868-F32CC0EE-1CD7-41F4-BDC3-63C08265523E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37119868-F32CC0EE-1CD7-41F4-BDC3-63C08265523E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
08fb635d964118cbd1555cecdc67a90115c27b4a
P2860
Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder.